HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis.

Abstract
Metastatic progression depends on genetic alterations intrinsic to cancer cells as well as the inflammatory microenvironment of advanced tumours. To understand how cancer cells affect the inflammatory microenvironment, we conducted a biochemical screen for macrophage-activating factors secreted by metastatic carcinomas. Here we show that, among the cell lines screened, Lewis lung carcinoma (LLC) were the most potent macrophage activators leading to production of interleukin-6 (IL-6) and tumour-necrosis factor-alpha (TNF-alpha) through activation of the Toll-like receptor (TLR) family members TLR2 and TLR6. Both TNF-alpha and TLR2 were found to be required for LLC metastasis. Biochemical purification of LLC-conditioned medium (LCM) led to identification of the extracellular matrix proteoglycan versican, which is upregulated in many human tumours including lung cancer, as a macrophage activator that acts through TLR2 and its co-receptors TLR6 and CD14. By activating TLR2:TLR6 complexes and inducing TNF-alpha secretion by myeloid cells, versican strongly enhances LLC metastatic growth. These results explain how advanced cancer cells usurp components of the host innate immune system, including bone-marrow-derived myeloid progenitors, to generate an inflammatory microenvironment hospitable for metastatic growth.
AuthorsSunhwa Kim, Hiroyuki Takahashi, Wan-Wan Lin, Pascal Descargues, Sergei Grivennikov, Youngjun Kim, Jun-Li Luo, Michael Karin
JournalNature (Nature) Vol. 457 Issue 7225 Pg. 102-6 (Jan 01 2009) ISSN: 1476-4687 [Electronic] England
PMID19122641 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Culture Media, Conditioned
  • Culture Media, Serum-Free
  • Interleukin-6
  • Lipopolysaccharide Receptors
  • Tlr2 protein, mouse
  • Tlr6 protein, mouse
  • Toll-Like Receptor 2
  • Toll-Like Receptor 6
  • Tumor Necrosis Factor-alpha
  • Versicans
Topics
  • Animals
  • Carcinoma, Lewis Lung (metabolism, pathology)
  • Culture Media, Conditioned (metabolism, pharmacology)
  • Culture Media, Serum-Free (metabolism)
  • Interleukin-6 (metabolism)
  • Lipopolysaccharide Receptors (metabolism)
  • Liver Neoplasms (secondary)
  • Lung Neoplasms (metabolism, pathology, secondary)
  • Macrophage Activation
  • Macrophages (metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Neoplasm Metastasis (pathology)
  • Neoplasm Transplantation
  • Toll-Like Receptor 2 (agonists, metabolism)
  • Toll-Like Receptor 6 (metabolism)
  • Tumor Necrosis Factor-alpha (metabolism)
  • Versicans (metabolism, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: